Mallinckrodt Fails To Halt Airgas' Generic Nitric Oxide Drug
By Andrea Keckley · February 13, 2025, 8:32 PM EST
A Delaware federal judge has rejected Mallinckrodt Pharmaceuticals' attempt to block French industrial gas company Airgas Healthcare from selling a generic version of its inhaled nitric oxide treatment, saying Mallinckrodt didn't...
To view the full article, register now.